FDA studying if gel for diabetic ulcers causes cancer


Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.

Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early company.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, clickhere.

Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Dr. Charles Lee
© 2024 MJH Life Sciences

All rights reserved.